Blockbuster weight loss drugs have been arguably the biggest health story of the last several years — and there are no signs ...

In July, the U.S. Food and Drug Administration warned that people are overdosing on compounded semaglutide injectable ...

Results from a new study showed people taking Wegovy (semaglutide) for weight loss were 33 percent less likely to die of COVID-19 than people taking placebo. They were also 15 percent less likely ...

Women who take Wegovy to treat obesity have the greatest likelihood of achieving 10% or more weight loss in a year, according to a Cleveland Clinic study published Friday. Michael Siluk ...

The move to self-administration with a syringe and needle, just like how insulin is often taken for diabetes, means a whole ...

A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the ...

If you buy through links on this page, we may earn a small commission. Here’s our process. Wegovy is a weight loss medication that you can only get with a prescription from a licensed healthcare ...

With so many kids already taking weight loss injectables like Ozempic, a new finding from the company behind the blockbuster ...

More Tennessee companies are covering weight-loss injections in health care benefit plans. This could impact the state's high ...

While GLP-1 medications like Ozempic and Wegovy hold promise for both weight loss and diabetes management, their potential for accidental misuse requires caution.

Novo Nordisk, maker of Ozempic and Wegovy, now has a market capitalization of more than ... who are willing to ...

9, 2024 (HealthDay News) -- A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to ... hydrogel doesn’t require a special syringe, researchers said.